PELIGROS DE LOS PROTECTORES SOLARES 2022 ¿DISRUPTORES ENDOCRINOS? ¿CÁNCER? ¿CORALES? OCTOCRILENO...

PELIGROS DE LOS PROTECTORES SOLARES 2022 ¿DISRUPTORES ENDOCRINOS? ¿CÁNCER? ¿CORALES? OCTOCRILENO...

Mi Instagram: https://instagram.com/dermisphere?utm...
Mi TikTok: https://vm.tiktok.com/ZM8gkQ9Ln/

BIBLIOGRAFÍA:
1. Berardesca E, Zuberbier T, Sanchez Viera M, Marinovich M. Review of the safety of octocrylene used as an ultraviolet filter in cosmetics. J Eur Acad Dermatol Venereol. 2019;33 Suppl 7:25-33. doi:10.1111/jdv.15945

2. Schneider SL, Lim HW. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol. 2019;80(1):266-271. doi:10.1016/j.jaad.2018.06.033

3. Matta MK, Florian J, Zusterzeel R, et al. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial [published correction appears in JAMA. 2020 Mar 17;323(11):1098]. JAMA. 2020;323(3):256-267. doi:10.1001/jama.2019.20747

4. Surber C, Plautz J, Sohn M, Maibach HI. Percutaneous Absorption of Sunscreen Filters: Review of Issues and Challenges. Curr Probl Dermatol. 2021;55:188-202. doi:10.1159/000517595

5. Dréno B, Alexis A, Chuberre B, Marinovich M. Safety of titanium dioxide nanoparticles in cosmetics. J Eur Acad Dermatol Venereol. 2019;33 Suppl 7:34-46. doi:10.1111/jdv.15943

6. Grande F, Tucci P. Titanium Dioxide Nanoparticles: a Risk for Human Health?. Mini Rev Med Chem. 2016;16(9):762-769. doi:10.2174/1389557516666160321114341

7. Robinson G, McMichael A, Wang SQ, Lim HW. Sunscreen and frontal fibrosing alopecia: A review. J Am Acad Dermatol. 2020;82(3):723-728. doi:10.1016/j.jaad.2019.09.085

8. Leecharoen W, Thanomkitti K, Thuangtong R, et al. Use of facial care products and frontal fibrosing alopecia: Coincidence or true association?. J Dermatol. 2021;48(10):1557-1563. doi:10.1111/1346-8138.16063

9. Olsen EA, Harries M, Tosti A, et al. Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG). Br J Dermatol. 2021;185(6):1221-1231. doi:10.1111/bjd.20567